← Back to Clinical Trials
Recruiting NCT06532500

I-CARE: A Pilot Study of Cognitive Behavioural Therapy(CBT) for Mood and Anxiety Disorders

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Mood Disorders
Sponsor Sunnybrook Health Sciences Centre
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 14 Years
Max Age 19 Years
Start Date 2024-10-24
Completion 2027-09-01
Interventions
CBT-MyOWLCBT-as-usual

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if CBT(Cognitive Behavioural Therapy)-MyOWL(Optimizing Wellness through Literature) is feasible, leads to better patient retention, and has high acceptability by youth psychiatric outpatients with mood and/or anxiety disorder aged 14-19. The main questions it aims to answer are: Primary Objective (feasibility): To determine whether a clinically meaningful proportion of youth complete a full course of CBT-MyOWL / CBT-as-usual. Primary Objective (acceptability): To determine whether the CBT-MyOWL and CBT-as-usual interventions delivered are acceptable to youth participants. Secondary Objectives: 1. To determine whether CBT-MyOWL enhances time of retention compared to CBT-as-usual. 2. To determine whether youth who receive CBT-MyOWL have improved scores on all of the following over the course of treatment and endpoint compared to youth who receive CBT-as usual: i) depression and anxiety ii) suicidal ideation, iii) self-harm, and iv) coping and emotional resiliency. Participants will: Participate in 12 sessions of either CBT-MyOWL or CBT-as-usual (active control) Completes 4-5 questionnaires at sessions 3,6,9,12 Complete the acceptability and exit interview at session 12

Eligibility Criteria

Inclusion Criteria: * Aged 14-19 * Primary diagnosis of a mood disorder or an anxiety disorder * Ability to understand written and spoken English and to read a novel * Treating physician considers CBT as indicated for the patient Exclusion Criteria: * Patients already participating in active CBT therapy or recently completed CBT treatment (within the past 3 months) * Active psychosis or mania

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}